N-Formyl-4-hydroxybenzamide

Details

Top
Internal ID a7a84da7-edad-4a08-9e14-2b22200056a5
Taxonomy Benzenoids > Benzene and substituted derivatives > Benzoic acids and derivatives
IUPAC Name N-formyl-4-hydroxybenzamide
SMILES (Canonical) C1=CC(=CC=C1C(=O)NC=O)O
SMILES (Isomeric) C1=CC(=CC=C1C(=O)NC=O)O
InChI InChI=1S/C8H7NO3/c10-5-9-8(12)6-1-3-7(11)4-2-6/h1-5,11H,(H,9,10,12)
InChI Key YFJMDGACSCLRLN-UHFFFAOYSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C8H7NO3
Molecular Weight 165.15 g/mol
Exact Mass 165.042593085 g/mol
Topological Polar Surface Area (TPSA) 66.40 Ų
XlogP 0.60
Atomic LogP (AlogP) 0.28
H-Bond Acceptor 3
H-Bond Donor 2
Rotatable Bonds 2

Synonyms

Top
65599-16-8
DTXSID50793399

2D Structure

Top
2D Structure of N-Formyl-4-hydroxybenzamide

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9917 99.17%
Caco-2 + 0.8535 85.35%
Blood Brain Barrier + 0.6250 62.50%
Human oral bioavailability - 0.6286 62.86%
Subcellular localzation Mitochondria 0.8399 83.99%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8249 82.49%
OATP1B3 inhibitior + 0.9649 96.49%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.9500 95.00%
BSEP inhibitior - 0.9736 97.36%
P-glycoprotein inhibitior - 0.9898 98.98%
P-glycoprotein substrate - 0.9263 92.63%
CYP3A4 substrate - 0.6789 67.89%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8412 84.12%
CYP3A4 inhibition - 0.9426 94.26%
CYP2C9 inhibition - 0.9868 98.68%
CYP2C19 inhibition - 0.9762 97.62%
CYP2D6 inhibition - 0.9156 91.56%
CYP1A2 inhibition - 0.9526 95.26%
CYP2C8 inhibition + 0.4470 44.70%
CYP inhibitory promiscuity - 0.9806 98.06%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.6434 64.34%
Carcinogenicity (trinary) Non-required 0.5145 51.45%
Eye corrosion - 0.9769 97.69%
Eye irritation + 0.9933 99.33%
Skin irritation + 0.5000 50.00%
Skin corrosion - 0.9778 97.78%
Ames mutagenesis - 0.7100 71.00%
Human Ether-a-go-go-Related Gene inhibition - 0.9013 90.13%
Micronuclear + 0.8400 84.00%
Hepatotoxicity + 0.5375 53.75%
skin sensitisation - 0.8772 87.72%
Respiratory toxicity - 0.6000 60.00%
Reproductive toxicity - 0.5333 53.33%
Mitochondrial toxicity + 0.6500 65.00%
Nephrotoxicity + 0.6615 66.15%
Acute Oral Toxicity (c) III 0.8082 80.82%
Estrogen receptor binding - 0.6914 69.14%
Androgen receptor binding - 0.5331 53.31%
Thyroid receptor binding - 0.7815 78.15%
Glucocorticoid receptor binding - 0.6678 66.78%
Aromatase binding - 0.6083 60.83%
PPAR gamma - 0.8058 80.58%
Honey bee toxicity - 0.9606 96.06%
Biodegradation + 0.5250 52.50%
Crustacea aquatic toxicity - 0.7400 74.00%
Fish aquatic toxicity - 0.5357 53.57%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 87.03% 95.56%
CHEMBL1907591 P30926 Neuronal acetylcholine receptor; alpha4/beta4 85.43% 100.00%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 84.93% 91.11%
CHEMBL4208 P20618 Proteasome component C5 84.70% 90.00%
CHEMBL3060 Q9Y345 Glycine transporter 2 84.12% 99.17%
CHEMBL2107 P61073 C-X-C chemokine receptor type 4 82.84% 93.10%
CHEMBL1293294 P51151 Ras-related protein Rab-9A 82.26% 87.67%
CHEMBL3194 P02766 Transthyretin 81.54% 90.71%
CHEMBL4072 P07858 Cathepsin B 81.27% 93.67%
CHEMBL5852 Q96P65 Pyroglutamylated RFamide peptide receptor 81.19% 85.00%

Cross-Links

Top
PubChem 71370414
NPASS NPC219870
LOTUS LTS0114093
wikiData Q82762659